NCCN 12th Annual Conference: Clinical Practice Guidelines in Oncology & Quality Cancer Care(TM) to Be Held March 14 - 18, 2007 in Hollywood, Florida
Posted on: Wednesday, 7 March 2007, 12:02 CST
Nearly 1,300 oncologists and cancer professionals have registered to attend the NCCN 12th Annual Conference: Clinical Practice Guidelines in Oncology & Quality Cancer Care™ taking place March 14 -- 18, 2007 at the Westin Diplomat in Hollywood, Florida. The program includes the presentation of the NCCN Clinical Practice Guidelines in Oncology™, updates from the NCCN PET/CT Imaging Task Force Report, and information about new cancer therapies and emerging issues in oncology business management.
During the opening session of the conference, ABC News veteran and anchor Sam Donaldson will moderate the roundtable discussion "The Role of the Journalist in the War on Cancer," which features top health reporters from television, national newspapers and the oncology trade press along with representatives from the oncology and patient advocacy communities. Panelists include:
Manny Alvarez, MD, Medical Correspondent for Fox News;
Catherine Arnst, Senior Writer, Science and Medicine for Business Week;
Robert Bazell, Chief Science and Health Correspondent for NBC News;
Nancy Davenport-Ennis, Chief Executive Officer for the National Patient Advocate Foundation;
Amy Dockser Marcus, Staff Reporter for The Wall Street Journal;
G. Timothy Johnson, MD, Medical Editor for ABC News (pending);
Caroline McNeil, Contributing Correspondent for the Journal of the National Cancer Institute; and
Robert C. Young, MD, President of Fox Chase Cancer Center.
Many of the conference sessions focus on new technologies and emerging trends in cancer care. This year's agenda includes the presentations "Cancer Stem Cells: New Targets for Cancer Prevention and Therapy"; "New Technologies in Robotic Surgery"; and "Biomarkers: New Paradigms in Cancer Management and Challenges." An additional roundtable entitled "Cancer Care: Cost, Access, and Value" will feature candid discussion by nationally recognized experts in the business, clinical and payor areas of oncology.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 20 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
The NCCN Member Institutions are: City of Hope Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Comprehensive Cancer Center, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University, Columbus, OH; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, Tampa, FL; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children's Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Comprehensive Cancer Center, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; and The University of Texas M. D. Anderson Cancer Center, Houston, TX.
For more information, visit www.nccn.org.
Source: Business Wire
Related Articles
- Nationally Recognized Multiple Myeloma Expert Dr. David Vesole Joins the John Theurer Cancer Center at Hackensack University Medical Center
- Velos, Inc. Releases Software to Support Cancer Centers With New Workflow and Content for NCI Clinical Trials Reporting Program
- Altrazeal(TM) Clinical Evidence to be Presented at The American Professional Wound Care Association (APWCA) National Clinical Conference 2009
- Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop 'Designer' Transplants
- Victoria Premier Visits World-Leading Cancer Center to Research a Comprehensive Care Facility for Victoria
- Texas Oncology-Baylor Sammons Cancer Center Recognized for Highest Commitment to Clinical Research at ASCO
- Researchers at The Cancer Center at Hackensack University Medical Center Participate in Study to Treat Advanced Melanoma
- Sigma-Aldrich Welcomes Vanderbilt-Ingram Cancer Center and the University of Michigan to the RNAi Partnership Program
- West Clinic Marks Opening of Cancer Center in Singapore
- Fox Chase Cancer Center Joins Dharmacon and International Research Institutes
User Comments (0)


RSS Feeds